296 related articles for article (PubMed ID: 37373135)
1. Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis.
Viglianisi G; Santonocito S; Polizzi A; Troiano G; Amato M; Zhurakivska K; Pesce P; Isola G
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373135
[TBL] [Abstract][Full Text] [Related]
2. Impact of periodontitis on circulating cell-free DNA levels as a measure of cardiovascular disease.
Isola G; Polizzi A; Mascitti M; Santonocito S; Ronsivalle V; Cicciù M; Pesce P
Clin Oral Investig; 2023 Nov; 27(11):6855-6863. PubMed ID: 37814162
[TBL] [Abstract][Full Text] [Related]
3. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives.
Thorsen SU; Moseholm KF; Clausen FB
Curr Opin Lipidol; 2024 Feb; 35(1):14-19. PubMed ID: 37800671
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
6. Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.
Sorbini M; Carradori T; Togliatto GM; Vaisitti T; Deaglio S
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672514
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis.
Huang H; Pan W; Wang Y; Kim HS; Shao D; Huang B; Ho TC; Lao YH; Quek CH; Shi J; Chen Q; Shi B; Zhang S; Zhao L; Leong KW
Nat Commun; 2022 Oct; 13(1):5925. PubMed ID: 36207325
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor necrosis factor-α DNA are elevated in psoriasis.
Sakamoto R; Sawamura S; Kajihara I; Miyauchi H; Urata K; Otsuka-Maeda S; Kanemaru H; Kanazawa-Yamada S; Honda N; Makino K; Miyashita A; Aoi J; Makino T; Fukushima S; Ihn H
J Dermatol; 2020 Sep; 47(9):1037-1040. PubMed ID: 32515034
[TBL] [Abstract][Full Text] [Related]
9. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
[TBL] [Abstract][Full Text] [Related]
11. Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases.
Duvvuri B; Lood C
Front Immunol; 2019; 10():502. PubMed ID: 30941136
[TBL] [Abstract][Full Text] [Related]
12. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.
Boublikova L; Kramarzova KS; Zwyrtkova M; Bakardjieva-Mihaylova V; Stuchly J; Rosova B; Kolostova K; Sonsky J; Kindlova E; Zachoval R; Buchler T; Trka J
Urol Oncol; 2022 Sep; 40(9):412.e15-412.e24. PubMed ID: 35729018
[TBL] [Abstract][Full Text] [Related]
16. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases.
Celec P; Vlková B; Lauková L; Bábíčková J; Boor P
Expert Rev Mol Med; 2018 Jan; 20():e1. PubMed ID: 29343314
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy.
Zwirner K; Hilke FJ; Demidov G; Ossowski S; Gani C; Rieß O; Zips D; Welz S; Schroeder C
Radiother Oncol; 2018 Dec; 129(3):575-581. PubMed ID: 30097252
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.
Carrasco R; Ingelmo-Torres M; Gómez A; Trullas R; Roldán FL; Ajami T; Moreno D; Rodríguez-Carunchio L; Alcaraz A; Izquierdo L; Mengual L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233035
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines.
Wang W; Kong P; Ma G; Li L; Zhu J; Xia T; Xie H; Zhou W; Wang S
Oncotarget; 2017 Jun; 8(26):43180-43191. PubMed ID: 28574818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
